Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
maria cappello
(97 results)?
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?
Biomolecules. 2023 Jun 8;13(6):967. doi: 10.3390/biom13060967.
Biomolecules. 2023.
PMID: 37371547
Free PMC article.
Review.
Pharmacology of Adenosine Receptors: Recent Advancements.
Vincenzi F, Pasquini S, Contri C, Cappello M, Nigro M, Travagli A, Merighi S, Gessi S, Borea PA, Varani K.
Vincenzi F, et al. Among authors: cappello m.
Biomolecules. 2023 Sep 14;13(9):1387. doi: 10.3390/biom13091387.
Biomolecules. 2023.
PMID: 37759787
Free PMC article.
Review.
Item in Clipboard
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications.
Pasquini S, Contri C, Cappello M, Borea PA, Varani K, Vincenzi F.
Pasquini S, et al. Among authors: cappello m.
Front Pharmacol. 2022 Oct 5;13:1030895. doi: 10.3389/fphar.2022.1030895. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36278183
Free PMC article.
Review.
Item in Clipboard
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents.
Papa A, Cursaro I, Pozzetti L, Contri C, Cappello M, Pasquini S, Carullo G, Ramunno A, Gemma S, Varani K, Butini S, Campiani G, Vincenzi F.
Papa A, et al. Among authors: cappello m.
Arch Pharm (Weinheim). 2023 Dec;356(12):e2300410. doi: 10.1002/ardp.202300410. Epub 2023 Sep 26.
Arch Pharm (Weinheim). 2023.
PMID: 37750286
Item in Clipboard
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients.
Rossi S, Tatangelo V, Dichiara M, Butini S, Gemma S, Brogi S, Pasquini S, Cappello M, Vincenzi F, Varani K, Lopresti L, Malchiodi M, Carrara C, Gozzetti A, Bocchia M, Marotta G, Patrussi L, Carullo G, Baldari CT, Campiani G.
Rossi S, et al. Among authors: cappello m.
Biomed Pharmacother. 2024 May;174:116537. doi: 10.1016/j.biopha.2024.116537. Epub 2024 Apr 4.
Biomed Pharmacother. 2024.
PMID: 38579402
Free article.
Item in Clipboard
Cite
Cite